Unknown

Dataset Information

0

Estrogen modulates metabolic pathway adaptation to available glucose in breast cancer cells.


ABSTRACT: Most cancers use glucose as substrate for aerobic glycolysis in preference to oxidative phosphorylation. However, variable glucose concentrations within the in-vivo tumor microenvironment may necessitate metabolic plasticity. Furthermore, little information exists on a role for estrogen receptors in modulating possible metabolic adaptations in breast cancer cells. Here we find that MCF-7 cells switch between metabolic pathways depending on glucose availability and 17?-estradiol (E(2)) potentiates adaptation. In high glucose conditions E(2) up-regulates glycolysis via enhanced AKT kinase activity and suppresses tricarboxylic acid cycle activity. After a decrease in extracellular glucose, mitochondrial pathways are activated in preference to glycolysis. In this setting, E(2) suppresses glycolysis and rescues cell viability by stimulating the tricarboxylic acid cycle via the up-regulation of pyruvate dehydrogenase (PDH) activity. E(2) also increases ATP in low glucose-cultured cells, and the novel phosphorylation of PDH by AMP kinase is required for these metabolic compensations. Capitalizing on metabolic vulnerability, knockdown of PDH in the low-glucose state strongly potentiates ionizing radiation-induced apoptosis and reverses the cell survival effects of E(2). We propose that lowering glucose substrate and inhibiting PDH may augment adjuvant therapies for estrogen receptor-positive breast cancer.

SUBMITTER: O'Mahony F 

PROVIDER: S-EPMC3517720 | biostudies-literature | 2012 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Estrogen modulates metabolic pathway adaptation to available glucose in breast cancer cells.

O'Mahony Fiona F   Razandi Mahnaz M   Pedram Ali A   Harvey Brian J BJ   Levin Ellis R ER  

Molecular endocrinology (Baltimore, Md.) 20121001 12


Most cancers use glucose as substrate for aerobic glycolysis in preference to oxidative phosphorylation. However, variable glucose concentrations within the in-vivo tumor microenvironment may necessitate metabolic plasticity. Furthermore, little information exists on a role for estrogen receptors in modulating possible metabolic adaptations in breast cancer cells. Here we find that MCF-7 cells switch between metabolic pathways depending on glucose availability and 17β-estradiol (E(2)) potentiate  ...[more]

Similar Datasets

| S-EPMC3715569 | biostudies-literature
| S-ECPF-GEOD-59535 | biostudies-other
| S-EPMC6959601 | biostudies-literature
| S-EPMC3591271 | biostudies-literature
| S-EPMC4674487 | biostudies-literature
| S-EPMC4728679 | biostudies-other
| S-EPMC2879563 | biostudies-literature
| S-EPMC5342103 | biostudies-literature
| S-EPMC8308983 | biostudies-literature
| S-EPMC3047816 | biostudies-other